SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-21-045426
Filing Date
2021-08-23
Accepted
2021-08-23 16:50:44
Documents
12
Period of Report
2021-08-20
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K acor-8k_20210820.htm   iXBRL 8-K 35188
  Complete submission text file 0001564590-21-045426.txt   160279

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA acor-20210820.xsd EX-101.SCH 5677
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE acor-20210820_lab.xml EX-101.LAB 18595
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE acor-20210820_pre.xml EX-101.PRE 11029
5 EXTRACTED XBRL INSTANCE DOCUMENT acor-8k_20210820_htm.xml XML 3413
Mailing Address 420 SAW MILL RIVER ROAD ARDSLEY NY 10502
Business Address 420 SAW MILL RIVER ROAD ARDSLEY NY 10502 914-347-4300
ACORDA THERAPEUTICS INC (Filer) CIK: 0001008848 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-31938 | Film No.: 211197524
SIC: 2836 Biological Products, (No Diagnostic Substances)